Edward E Partridge Selected Research

Uterine Cervical Neoplasms (Cancer of the Cervix)

1/2017	A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome.
1/2017	Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
1/2016	Accuracy of urinary human papillomavirus testing for the presence of cervical human papillomaviruses and higher grades of cervical intraepithelial neoplasia.
12/2014	Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection.
3/2013	Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta.
12/2011	Comparative performance of human papillomavirus DNA testing using novel sample collection methods.
3/2011	A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia.
8/2010	Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or high-risk (HR) types of human papillomaviruses (HPVs).
7/2009	Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era.
10/2007	An examination of acceptability of HPV vaccination among African American women and Latina immigrants.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward E Partridge Research Topics

Disease

14	Neoplasms (Cancer) 01/2018 - 04/2003
14	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 01/2002
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 12/2004
11	Uterine Cervical Dysplasia 03/2012 - 12/2004
10	Carcinoma (Carcinomatosis) 01/2014 - 01/2002
6	Ovarian Epithelial Carcinoma 01/2014 - 04/2006
5	Papillomavirus Infections 01/2016 - 12/2004
3	Disease Progression 04/2007 - 08/2002
3	Carcinogenesis 12/2004 - 01/2002
2	Breast Neoplasms (Breast Cancer) 01/2018 - 12/2011
2	Body Weight (Weight, Body) 01/2016 - 01/2013
2	Infections 03/2011 - 04/2003
2	Adenocarcinoma 05/2003 - 10/2002
2	Endometrial Neoplasms (Endometrial Cancer) 05/2003 - 02/2002
1	Chronic Disease (Chronic Diseases) 01/2016
1	Insulin Resistance 01/2013
1	Sarcoma (Soft Tissue Sarcoma) 02/2004
1	Neoplasm Metastasis (Metastasis) 01/2004
1	Papillary Carcinoma 04/2003

Drug/Important Bio-Agent (IBA)

7	Folic Acid (Vitamin M)FDA LinkGeneric 01/2013 - 12/2004
5	Proteins (Proteins, Gene)FDA Link 01/2014 - 02/2007
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2005
4	Biomarkers (Surrogate Marker)IBA 03/2012 - 10/2003
4	PlatinumIBA 04/2007 - 04/2006
3	EnzymesIBA 01/2017 - 01/2002
3	VaccinesIBA 01/2016 - 01/2007
3	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 05/2011 - 07/2009
3	MicronutrientsIBA 03/2011 - 12/2004
2	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2016 - 10/2007
2	Blood Proteins (Serum Proteins)IBA 01/2011 - 02/2007
2	Cisplatin (Platino)FDA LinkGeneric 06/2010 - 04/2003
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 03/2007 - 03/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2005 - 01/2002
2	tumor-associated antigen 72IBA 10/2003 - 09/2002
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2002 - 01/2002
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	MethyltransferasesIBA 01/2017
1	TransferasesIBA 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	XenobioticsIBA 12/2014
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 12/2014
1	Caveolin 1IBA 01/2014
1	Complement System Proteins (Complement)IBA 03/2013
1	Small Interfering RNA (siRNA)IBA 01/2012
1	CarbonIBA 05/2011
1	Metalloproteases (Metalloproteinases)IBA 07/2010
1	CC ChemokinesIBA 06/2010
1	Riboflavin (Vitamin B2)FDA LinkGeneric 03/2007
1	Topotecan (Hycamtin)FDA LinkGeneric 03/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2006
1	liposomal doxorubicin (Doxil)FDA Link 04/2006
1	1-dodecylpyridoxal (PLD)IBA 04/2006
1	Celecoxib (Celebrex)FDA Link 09/2005
1	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 03/2005
1	Coenzymes (Enzyme Cofactors)IBA 03/2005
1	Carotenoids (Carotene)IBA 12/2004
1	VitaminsIBA 12/2004
1	Formaldehyde (Formol)FDA Link 02/2004
1	Imatinib Mesylate (Gleevec)FDA Link 02/2004
1	ParaffinIBA 02/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2004
1	Lewis Y antigenIBA 10/2003
1	Carcinoembryonic AntigenIBA 10/2003
1	placental alkaline phosphataseIBA 04/2003
1	enhanced green fluorescent proteinIBA 04/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2003
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 10/2002
1	Oral ContraceptivesIBA 07/2002
1	RetinoidsIBA 07/2002
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2002
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2002
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2002

Therapy/Procedure

10	Therapeutics 01/2018 - 04/2003
6	Drug Therapy (Chemotherapy) 06/2017 - 08/2002
4	Radiotherapy 01/2018 - 02/2002
4	Chemoprevention 09/2005 - 01/2002
3	Hysterectomy 01/2017 - 01/2004
2	Lasers (Laser) 01/2011 - 02/2007
1	Episode of Care 01/2018
1	Precision Medicine 08/2017
1	Genomic Medicine 08/2017
1	Aftercare (After-Treatment) 01/2016
1	Combination Drug Therapy (Combination Chemotherapy) 08/2006
1	Complementary Therapies (Alternative Medicine) 10/2003
1	Radioimmunotherapy 09/2002
1	Salvage Therapy 08/2002
1	Palliative Care (Palliative Therapy) 08/2002
1	Tubal Sterilization (Tubal Ligation) 07/2002
1	Ovariectomy (Oophorectomy) 07/2002
1	Conservative Treatment 02/2002